NEWS IN BRIEF: Hill & Knowlton selected by Sankyo Pharma

NEW YORK: Hill & Knowlton's New York healthcare practice has been selected by Sankyo Pharma to represent its GlucoWatch brand - an automatic, noninvasive glucose-monitoring system that is worn like a wristwatch. The brand joins two other Sankyo products already on H&K's roster: WelChol, a cholesterol-lowering medication, and Benicar, the company's hypertension treatment.

NEW YORK: Hill & Knowlton's New York healthcare practice has been selected by Sankyo Pharma to represent its GlucoWatch brand - an automatic, noninvasive glucose-monitoring system that is worn like a wristwatch. The brand joins two other Sankyo products already on H&K's roster: WelChol, a cholesterol-lowering medication, and Benicar, the company's hypertension treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in